Evidence map›Paper›PMID 31711453›Full record

ArticleBMC cancer2019

Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients.

Manman Li, Hailong Xia, Huimin Zheng, Yafeng Li, Jun Liu, Linhui Hu, Jingrong Li, Yangyang Ding, Lianfang Pu, Qianle Gui and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Clinical scoring systems, molecular subtypes and baseline [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Manman LiDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Hailong XiaDepartment of Hematology, Chaohu Hospital of Anhui Medical University, Chaohu, 238000, People's Republic of China.
Huimin ZhengDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Yafeng LiDepartment of Hematology, The First Hospital of Anhui Medical University, Hefei, 230000, People's Republic of China.
Jun LiuDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Linhui HuDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Jingrong LiDepartment of Emergency, The Second Hospital of Anhui Medical university, Hefei, 230601, Anhui Province, People's Republic of China.
Yangyang DingDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Lianfang PuDepartment of Hematology, The Third People's Hospital of Bengbu, Bengbu, 233000, People's Republic of China.
Qianle GuiDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Yijie ZhengDepartment of Immunology and Key Laboratory of Molecular Medicine of Ministry Education, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.
Zhimin ZhaiDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China.
Shudao XiongDepartment of Hematology/Hematological Lab, The Second Hospital of Anhui Medical University, Hefei, Anhui Province, 230601, People's Republic of China. xshdao@ahmu.edu.cn.ORCID http://orcid.org/0000-0001-5560-1936
Anhui Medical University · CNBengbu Medical College · CNChaohu Hospital of Anhui Medical University · CNShanghai Medical College of Fudan University · CN

Funding

National Natural Science Foundation of China 81272259Natural Science Foundation of Anhui Province KJ2018A0198
6 · The paper itself

Abstract

backgroundElevated red blood cell distribution width (RDW) and decreased platelet count (PLT) can be clinically relevant to the prognosis in cancer patients. However, their prognostic values in patients with diffuse large B-cell lymphoma (DLBCL) need to be further explored.

methodsHealthy donors (n = 130) and patients with DLBCL (n = 349) were included and evaluated retrospectively in this study. The prognostic influence of clinical and pathological factors including RDW and PLT on overall survival (OS) and progression-free survival (PFS) were studied by Kaplan-Meier curves. To evaluate the independent prognostic relevance of RDW and PLT, univariate and multivariate Cox proportional hazards regression models were applied. The adjusted IPI model was established based on the results of multivariate analysis, and verified by Harrell's C statistical analysis.

resultsKaplan-Meier curves indicated that an elevated RDW value and thrombocytopenia are poor factors for OS (P < 0.001, P = 0.006) and PFS (P = 0.003, P < 0.001) in DLBCL patients. Multivariate analysis confirmed that elevated RDW value (HR = 2.026, 95%CI = 1.263-3.250, P = 0.003) and decreased PLT count (HR =1.749, 95%CI = 1.010-3.028, P = 0.046) were both independent prognostic factors. The c-index of IPI and NCCN-IPI were increased when RDW level and PLT were supplemented in our cohort.

conclusionsOur study shows that elevated RDW level and decreased PLT are independent poor prognostic factors in newly diagnosed DLBCL patients. Adding RDW and PLT to the IPI score may improve its predictive ability, and the adjusted IPI may be more powerful in predicting the survival of DLBCL patients in the rituximab era.

Indexed as

NomogramsBiomarkers, TumorBlood PlateletsCase-Control StudiesErythrocyte IndicesErythrocytesFemaleHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedPlatelet CountPrognosisRetrospective StudiesBiomarkers, TumorDiffuse large B-cell lymphoma (DLBCL)Platelet count (PLT)PrognosisRed blood cell distribution width (RDW)

Identifiers

PMID31711453
PMCPMC6849243
OpenAlexW2983850137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.